Carbamazepine cutaneous adverse reactions andHLAgene variation in the Chinese population: a systematic review and meta-analysis

Author:

Meng Qingli12ORCID,Gu Hongyan12ORCID,Zhang Qinghua12,Yi Zhanmiao34ORCID,Jiang Dechun12

Affiliation:

1. Department of Pharmacy, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China

2. Beijing Key Laboratory of Evaluation of Rational Drug Use, Beijing, 100038, China

3. Department of Pharmacy, Peking University Third Hospital, Beijing, 100191, China

4. Institute for drug evaluation, Peking University Health Science Center, Beijing, 100191, China.

Abstract

Aim: Examining the association between HLA-A/B alleles and different carbamazepine (CBZ)-induced cutaneous adverse reactions in the Chinese population. Methods: A systematic review and meta-analysis of case–control studies was conducted. A systematic search was conducted of PubMed, Embase, the Cochrane Library, National Knowledge Infrastructure, the Chinese Biomedical Literature database and Wanfang Digital Periodicals. Results: 23 studies with a total of 1174 patients were included. In the Han population, HLA-B*15:02 is significantly associated with the increased risk of CBZ-related Stevens–Johnson syndrome/toxic epidermal necrolysis, and this correlation was not related to geographic distribution. HLA-A*31:01, B*38:02 are associated with CBZ-related maculopapular eruption in South Han population. HLA-A*31:01 is associated with CBZ-DRESS in Taiwan Han population. Conclusion: HLA-B*15:02, A*31:01 and B*38:02 genes were found to be involved in the occurrence of CBZ cutaneous adverse reactions in Han Chinese.

Funder

National Key R&D Program of China

Publisher

Future Medicine Ltd

Subject

Pharmacology,Genetics,Molecular Medicine

Reference41 articles.

1. National Medical Products Administration. Pharmacovigilance alerts [DB/OL] (2008). www.nmpa.gov.cn/xxgk/yjjsh/ywjjkx/20080128120001639.html.

2. Medlive. Instructions for Carbamazepine [DB/OL] (2022). https://drugs.medlive.cn/drugref/html/12835.shtml

3. A marker for Stevens–Johnson syndrome

4. HLA-A*24:02 as a common risk factor for antiepileptic drug–induced cutaneous adverse reactions

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3